PDT Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,905	Closed	-$281K	–	945
2021 Q2	$281K	Buy	3,905 +628	+19%	+$46.1K	0.02%	625
2021 Q1	$242K	Buy	+3,277	New	+$249K	0.02%	660
2020 Q4	–	Sell	-4,800	Closed	-$263K	–	882
2020 Q3	$263K	Sell	4,800 -1,300	-21%	-$80.9K	0.02%	570
2020 Q2	$406K	Sell	6,100 -2,000	-25%	-$134K	0.03%	463
2020 Q1	$496K	Hold	8,100	–	–	0.04%	373
2019 Q4	$712K	Buy	+8,100	New	+$683K	0.04%	345
2015 Q3	–	Sell	-18,512	Closed	-$2.66M	–	1629
2015 Q2	$2.66M	Buy	18,512 +772	+4%	+$110K	0.07%	336
2015 Q1	$2.5M	Buy	17,740 +11,240	+173%	+$1.73M	0.06%	388
2014 Q4	$963K	Buy	6,500 +1,200	+23%	+$176K	0.09%	308
2014 Q3	$815K	Buy	5,300 +1,000	+23%	+$151K	0.02%	769
2014 Q2	$603K	Sell	4,300 -1,129	-21%	-$125K	0.02%	886
2014 Q1	$603K	Buy	5,429 +2,040	+60%	+$222K	0.01%	854
2013 Q4	$335K	Buy	3,389 +94	+3%	+$8.15K	0.04%	511
2013 Q3	$250K	Sell	3,295 -3,169	-49%	-$206K	0.01%	1324
2013 Q2	$361K	Buy	+6,464	New	+$382K	0.01%	1199